UnitedHealth Group Incorporated UNH is refining its Medicare Advantage strategy, emphasizing high-value health maintenance organization (HMO) plans and specialized coverage for seniors with complex healthcare needs. For 2027, UnitedHealthcare plans to prioritize Chronic Special Needs Plans (C-SNPs) and Dual Eligible Special Needs Plans (D-SNPs).
The opportunity is substantial. UnitedHealthcare's C-SNPs will be available to nearly 50 million Medicare-eligible individuals in 2027, offering tailored support for people managing conditions such as diabetes, cardiovascular disease and chronic heart failure. Meanwhile, its D-SNPs will reach approximately 74% of dual-eligible individuals, facilitating coordinated Medicare and Medicaid benefits. These plans can connect members with more coordinated care, medication support and preventive services, potentially creating opportunities to improve outcomes and limit avoidable healthcare spending.
UNH's approach also fits its broader shift toward more selective Medicare Advantage offerings. The company is adjusting plan benefits and market participation to better align coverage with healthcare costs. It expects Medicare margins to approach the upper end of its 2%-4% target range in 2026, reflecting improved cost management and product positioning. Integrated care through Optum Health could further support this strategy by coordinating services for members with complex needs.
Star ratings remain another consideration. UnitedHealthcare reported that at least 69% of its Medicare Advantage members are in plans rated four stars or higher for 2027. UNH's focus on special needs plans could support targeted growth, but execution, medical costs and quality performance can shape the results.
How Are Competitors Faring?
Some of UNH’s major competitors in the healthcare service provider space are Humana Inc. HUM and Centene Corporation CNC.
Humana is expanding its Chronic Condition Special Needs Plans into Pennsylvania, Utah and Wisconsin for 2027. HUM’s focus on tailored coverage and coordinated care could attract beneficiaries with complex conditions, while stronger Star Ratings may support its Medicare Advantage competitiveness.
Through its Wellcare brand, Centene is emphasizing affordable Medicare Advantage coverage and integrated care for dual-eligible beneficiaries in 2027. CNC’s coordinated Medicare-Medicaid offerings could strengthen its appeal among members with complex needs, although managing medical expenses remains key.
UnitedHealth’s Price Performance, Valuation & Estimates
Shares of UNH have gained 19.5% in the year-to-date period compared with the industry’s rise of 22.9%.
Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 18, above the industry average of 15.73. UNH carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2026 earnings is pegged at $19.85 per share, implying 21.4% growth from the year-ago period.
Image Source: Zacks Investment Research
UNH stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
Humana Inc. (HUM): Free Stock Analysis Report
Centene Corporation (CNC): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).